Chan also reported an increased risk of RM in patients with some hereditary neuromuscular diseases, such as Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD), fukutin-related protein, dysferlin, γ-sarcoglycans, and anoctamin 5 deficiency-associated muscular atrophy (21). Here, ANO5 is linked to neuromuscular disease.